Working… Menu

Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 (SEMPATICO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04615871
Recruitment Status : Not yet recruiting
First Posted : November 4, 2020
Last Update Posted : November 4, 2020
Unity Health Toronto
Canadian Institutes of Health Research (CIHR)
University of Toronto
Information provided by (Responsible Party):
Vladimír Džavík, University Health Network, Toronto

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : March 31, 2022